Asia Vital Components (3017) Q3 2025 earnings summary

Executive summary

• Revenue for the nine months ended September 30, 2025, reached NT$91.86 billion, up from NT$50.86 billion year-over-year, with net income at NT$12.55 billion, more than doubling from NT$5.83 billion in the prior year period.

• Gross margin improved to 25% from 23% year-over-year, and operating income rose to NT$17.54 billion from NT$7.47 billion.

• Earnings per share (EPS) for the nine-month period were NT$32.25 basic and NT$31.54 diluted, compared to NT$15.18 and NT$14.77, respectively, in the prior year.

Financial highlights

• Total assets as of September 30, 2025, were NT$139.25 billion, up from NT$88.10 billion a year earlier.

• Cash and cash equivalents increased to NT$43.79 billion from NT$30.01 billion year-over-year.

• Short-term loans rose to NT$14.80 billion from NT$8.25 billion, and long-term borrowings (net) were NT$5.56 billion.

• Operating cash flow for the nine months was NT$25.93 billion, up from NT$11.06 billion year-over-year.

Outlook and guidance

• The company adopted new IFRS standards effective January 1, 2025, with no material impact expected.

• Management continues to monitor the impact of future IFRS changes, including IFRS 18 and IFRS 19, with local adoption expected in 2028.